Concorde Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-5,045
| Closed | -$442K | – | 160 |
|
|
2017
Q3 | $442K | Sell |
5,045
-871
| -15% | -$76.3K | 0.38% | 76 |
|
|
2017
Q2 | $456K | Sell |
5,916
-941
| -14% | -$72.5K | 0.62% | 61 |
|
|
2017
Q1 | $469K | Sell |
6,857
-634
| -8% | -$43.4K | 0.77% | 44 |
|
|
2016
Q4 | $388K | Sell |
7,491
-3,468
| -32% | -$180K | 0.7% | 54 |
|
|
2016
Q3 | $726K | Sell |
10,959
-1,278
| -10% | -$84.7K | 0.91% | 32 |
|
|
2016
Q2 | $607K | Sell |
12,237
-3,334
| -21% | -$165K | 0.6% | 38 |
|
|
2016
Q1 | $815K | Sell |
15,571
-3,392
| -18% | -$178K | 0.94% | 30 |
|
|
2015
Q4 | $1.33M | Sell |
18,963
-407
| -2% | -$28.6K | 1.48% | 17 |
|
|
2015
Q3 | $1.21M | Buy |
19,370
+1,334
| +7% | +$83.1K | 2.04% | 12 |
|
|
2015
Q2 | $1.52M | Buy |
+18,036
| New | +$1.52M | 1.93% | 15 |
|